BIOMARIN PHARMACEUTICAL INC — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B2
424B3
424B4
424B5
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000752 | Mar 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-019862 | Mar 19, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001628280-26-019857 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019853 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019847 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019269 | Mar 18, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001628280-26-019266 | Mar 18, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001628280-26-019012 | Mar 17, 2026 | Mar 13, 2026 |
| 4 | FORM 4 | 0001628280-26-019010 | Mar 17, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001628280-26-019008 | Mar 17, 2026 | Mar 13, 2026 |
| 4 | FORM 4 | 0001628280-26-019006 | Mar 17, 2026 | Mar 13, 2026 |
| 8-K | 8-K | 0001193125-26-107314 | Mar 16, 2026 | — |
| 4 | FORM 4 | 0001628280-26-017447 | Mar 12, 2026 | Mar 11, 2026 |
| 144 | — | 0001959173-26-002210 | Mar 11, 2026 | — |
| 4 | FORM 4 | 0001628280-26-012542 | Feb 26, 2026 | Feb 25, 2026 |
| 4 | FORM 4 | 0001628280-26-012539 | Feb 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-012533 | Feb 26, 2026 | Feb 25, 2026 |
| 4 | FORM 4 | 0001628280-26-012529 | Feb 26, 2026 | Feb 25, 2026 |
| 144 | — | 0001959173-26-001526 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001048477-26-000004 | Feb 26, 2026 | Dec 31, 2025 |
| 144 | — | 0001959173-26-001510 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001048477-26-000002 | Feb 23, 2026 | — |
| 5 | FORM 5 | 0001628280-26-008254 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | FORM 5 | 0001628280-26-008241 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | FORM 5 | 0001628280-26-008231 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | FORM 5 | 0001628280-26-008221 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | FORM 5 | 0001628280-26-008218 | Feb 13, 2026 | Dec 31, 2025 |
| 5 | FORM 5 | 0001628280-26-008216 | Feb 13, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-048736 | Feb 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-029401 | Jan 29, 2026 | — |
| 8-K | 8-K | 0001193125-26-021718 | Jan 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-003139 | Jan 22, 2026 | Jan 20, 2026 |
| 3 | FORM 3 | 0001628280-26-003137 | Jan 22, 2026 | Jan 20, 2026 |
| SCHEDULE 13G/A | — | 0002012383-26-000650 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001193125-26-010508 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001193125-25-327828 | Dec 22, 2025 | Dec 19, 2025 |
| 8-K | 8-K | 0001193125-25-325856 | Dec 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-322704 | Dec 17, 2025 | Dec 11, 2025 |
| 4 | FORM 4 | 0001628280-25-054856 | Dec 2, 2025 | Dec 1, 2025 |
| SCHEDULE 13G/A | — | 0000905148-25-004061 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001048477-25-000107 | Oct 28, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001048477-25-000104 | Oct 27, 2025 | — |
| 8-K | 8-K | 0001048477-25-000101 | Oct 7, 2025 | — |
| 4 | FORM 4 | 0002038768-25-000007 | Oct 2, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0000905148-25-002994 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001085146-25-005169 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001048477-25-000098 | Aug 11, 2025 | Aug 5, 2025 |
| 4 | FORM 4 | 0001048477-25-000095 | Aug 5, 2025 | Aug 1, 2025 |
| 3 | FORM 3 | 0001048477-25-000093 | Aug 5, 2025 | Aug 1, 2025 |
| S-8 | S-8 | 0001193125-25-173541 | Aug 5, 2025 | — |